PCRX - Pacira BioSciences Inc
IEX Last Trade
15.58
0.220 1.412%
Share volume: 702,297
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$15.36
0.22
1.43%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-03 | 2023-02-28 | 2023-05-03 | 2023-08-02 | 2023-11-02 | 2024-02-29 | 2024-05-07 | 2024-07-30 | |
| Assets | |||||||||
| Total Assets | 1.734 B | 1.681 B | 1.523 B | 1.542 B | 1.534 B | 1.574 B | 1.583 B | 1.647 B | |
| Current Assets | 533.411 M | 498.334 M | 376.114 M | 429.324 M | 447.255 M | 509.994 M | 543.113 M | 632.214 M | |
| Inventories | 96.799 M | 96.063 M | 92.977 M | 92.130 M | 96.520 M | 104.353 M | 96.782 M | 103.438 M | |
| Other Current Assets | 14.416 M | 15.223 M | 15.933 M | 17.349 M | 18.591 M | 21.504 M | 18.802 M | 19.771 M | |
| Short Term Investments | 14.416 M | 15.223 M | 15.933 M | 17.349 M | 18.591 M | 21.504 M | 18.802 M | 19.771 M | |
| Total Receivables | 93.471 M | 98.397 M | 93.205 M | 99.079 M | 96.956 M | 105.556 M | 101.639 M | 104.779 M | |
| Current Cash | 328.725 M | 288.651 M | 173.999 M | 220.766 M | 235.188 M | 278.581 M | 325.890 M | 404.226 M | |
| Total Non-current Assets | 1.201 B | 1.183 B | 1.147 B | 1.113 B | 1.087 B | 1.064 B | 1.040 B | 1.015 B | |
| Property Plant Equipment | 193.646 M | 183.512 M | 181.617 M | 180.310 M | 175.783 M | 173.927 M | 171.804 M | 168.850 M | |
| Other Assets | 26.358 M | 27.170 M | 32.285 M | 35.625 M | 35.547 M | 36.049 M | 36.542 M | 36.499 M | |
| Intangible Assets | 581.002 M | 540.546 M | 526.224 M | 511.902 M | 497.580 M | 483.258 M | 468.936 M | 454.614 M | |
| Goodwill | 157.361 M | 163.243 M | 163.243 M | 163.243 M | 163.243 M | 163.243 M | 163.243 M | 163.243 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.734 B | 1.681 B | 1.523 B | 1.542 B | 1.534 B | 1.574 B | 1.583 B | 1.647 B | |
| Total liabilities | 964.242 M | 906.190 M | 755.377 M | 734.406 M | 702.911 M | 704.256 M | 691.159 M | 767.542 M | |
| Total current liabilities | 131.526 M | 147.774 M | 98.698 M | 108.912 M | 93.661 M | 97.383 M | 93.444 M | 92.690 M | |
| Accounts Payable | 12.933 M | 15.220 M | 17.261 M | 24.206 M | 16.511 M | 15.698 M | 8.982 M | 18.730 M | |
| Other liabilities | 53.316 M | 37.791 M | 51.319 M | 33.265 M | 36.220 M | 38.271 M | 33.582 M | 35.406 M | |
| Current long term debt | 33.872 M | 33.648 M | 10.853 M | 19.504 M | 8.641 M | 8.641 M | 8.641 M | 0.000 | |
| Long term debt | 713.999 M | 655.823 M | 542.918 M | 532.183 M | 515.941 M | 513.796 M | 511.687 M | 589.300 M | |
| Other liabilities | 53.316 M | 37.791 M | 51.319 M | 33.265 M | 36.220 M | 38.271 M | 33.582 M | 35.406 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 770.123 M | 775.010 M | 768.041 M | 807.975 M | 831.551 M | 870.130 M | 892.162 M | 879.278 M | |
| Common stock | 45.831 M | 45.883 M | 45.949 M | 46.088 M | 46.416 M | 46.435 M | 46.499 M | 46.174 M | |
| Retained earnings | -138.649 M | -148.751 M | -168.287 M | -142.524 M | -131.666 M | -106.796 M | -97.817 M | -78.931 M |